Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

ASAS recommendations for collecting, analysing and reporting NSAID intake in clinical trials/epidemiological studies in axial spondyloarthritis.

Dougados M, Simon P, Braun J, Burgos-Vargas R, Maksymowych WP, Sieper J, van der Heijde D.

Ann Rheum Dis. 2011 Feb;70(2):249-51. doi: 10.1136/ard.2010.133488.

PMID:
20829199
2.
3.
4.

Discriminant Capacity of Clinical Efficacy and Nonsteroidal Antiinflammatory Drug-sparing Endpoints, Alone or in Combination, in Axial Spondyloarthritis.

Dougados M, Wood E, Gossec L, Dubanchet A, Logeart I, van der Heijde D.

J Rheumatol. 2015 Dec;42(12):2361-8. doi: 10.3899/jrheum.150378.

PMID:
26568588
5.

Efficacy and safety of infliximab plus naproxen versus naproxen alone in patients with early, active axial spondyloarthritis: results from the double-blind, placebo-controlled INFAST study, Part 1.

Sieper J, Lenaerts J, Wollenhaupt J, Rudwaleit M, Mazurov VI, Myasoutova L, Park S, Song Y, Yao R, Chitkara D, Vastesaeger N; All INFAST Investigators..

Ann Rheum Dis. 2014 Jan;73(1):101-7. doi: 10.1136/annrheumdis-2012-203201.

6.

The concept of axial spondyloarthritis. Lessons from the INFAST study.

Zeidler H.

Ann Rheum Dis. 2014 Apr;73(4):e18. doi: 10.1136/annrheumdis-2013-204940. No abstract available.

PMID:
24318860
7.

2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis.

van der Heijde D, Sieper J, Maksymowych WP, Dougados M, Burgos-Vargas R, Landewé R, Rudwaleit M, Braun J; Assessment of SpondyloArthritis international Society..

Ann Rheum Dis. 2011 Jun;70(6):905-8. doi: 10.1136/ard.2011.151563.

PMID:
21540200
8.
9.

Response to H Zeidler's comments on the INFAST study.

Sieper J.

Ann Rheum Dis. 2014 Apr;73(4):e19. doi: 10.1136/annrheumdis-2013-204955. No abstract available.

PMID:
24470538
10.

Dose-effect relationships of nonsteroidal anti-inflammatory drugs: a literature review.

Emery P, Kong SX, Ehrich EW, Watson DJ, Towheed TE.

Clin Ther. 2002 Aug;24(8):1225-91. Review.

PMID:
12240779
12.

Therapeutic controversies in spondyloarthritis: nonsteroidal anti-inflammatory drugs.

Poddubnyy D, van der Heijde D.

Rheum Dis Clin North Am. 2012 Aug;38(3):601-11. doi: 10.1016/j.rdc.2012.08.005. Review.

PMID:
23083758
13.

Canadian Rheumatology Association Consensus on the use of anti-tumor necrosis factor-alpha directed therapies in the treatment of spondyloarthritis.

Maksymowych WP, Inman RD, Gladman D, Thomson G, Stone M, Karsh J, Russell AS; Spondyloarthritis Research Consortium of Canada (SPARCC)..

J Rheumatol. 2003 Jun;30(6):1356-63. Review.

PMID:
12784417
14.

Aceclofenac in the management of inflammatory pain.

Legrand E.

Expert Opin Pharmacother. 2004 Jun;5(6):1347-57. Review.

PMID:
15163279
15.

Pooled analysis of GI tolerability of 21 randomized controlled trials of celecoxib and nonselective NSAIDs.

Niculescu L, Li C, Huang J, Mallen S.

Curr Med Res Opin. 2009 Mar;25(3):729-40. doi: 10.1185/03007990802714382 .

PMID:
19210159
16.

An international study on starting tumour necrosis factor-blocking agents in ankylosing spondylitis.

Pham T, Landewé R, van der Linden S, Dougados M, Sieper J, Braun J, Davis J, Rudwaleit M, Collantes E, Burgos-Vargas R, Edmonds J, Olivieri I, van der Horst-Bruinsma I, Mielants H, Stone M, Emery P, van der Heijde D.

Ann Rheum Dis. 2006 Dec;65(12):1620-5.

17.
18.

Nonsteroidal anti-inflammatory drug use in ankylosing spondylitis--a population-based survey.

Zochling J, Bohl-Bühler MH, Baraliakos X, Feldtkeller E, Braun J.

Clin Rheumatol. 2006 Nov;25(6):794-800.

PMID:
16528455
19.

Ximoprofen in ankylosing spondylitis. A double blind placebo controlled dose ranging study.

Dougados M, Nguyen M, Caporal R, Legeais J, Bouxin-Sauzet A, Pellegri-Guegnault B, Gomeni C.

Scand J Rheumatol. 1994;23(5):243-8.

PMID:
7973477
20.

International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis.

Braun J, Pham T, Sieper J, Davis J, van der Linden S, Dougados M, van der Heijde D; ASAS Working Group..

Ann Rheum Dis. 2003 Sep;62(9):817-24. Review.

Items per page

Supplemental Content

Support Center